EcoDrugPlus

Ensembl ID : ENSHCOG00000009143
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSHCOG00000015992
Gene Symbol: -
Cross references: -
156 Possible Orthologues:

Ensembl ID : ENSHCOG00000013129
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSHCOG00000015076
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSHCOG00000005621
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSHCOG00000016232
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSHCOG00000016253
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSHCOG00000010592
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSHCOG00000018331
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSHCOG00000003705
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSHCOG00000005098
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSHCOG00000006904
Gene Symbol: -
Cross references: -
263 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).